S. Rothenberg
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
S.
Michael Rothenberg is currently an Independent Director at Tyra Biosciences, Inc. since 2024 and Chief Medical Officer at Insitro, Inc. since 2024.
Formerly, served as Vice President-Research & Development at Loxo Oncology, Inc. from 2015 to 2020.
Education includes undergraduate studies at Yale University and a doctorate from Stanford University School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TYRA BIOSCIENCE, INC -.--% | 28/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| TYRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 07/05/2024 |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Directeur Technique/Scientifique/R&D | 01/02/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| LOXO ONCOLOGY INC | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loxo Oncology, Inc.
Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Insitro, Inc.
Insitro, Inc. BiotechnologyHealth Technology Operates as a biology based AI therapeutics company | Health Technology |
Tyra Biosciences, Inc.
Tyra Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops cancer treatment drug therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national